The discovery of a protein that triggers inflammation during bacterial
and viral infections solves a 40-year-old problem and presents a tempting
target for drug development, write researchers in the July 20 online edition
In a statement, team leader Bruce Beutler, MD, of the Scripps Research
Institute in La Jolla, Calif, characterized the protein, Trif, as standing
at the crossroads of innate immunity in mice, and probably in humans.
Brian Vastag. Transforming Mental Health Care. JAMA. 2003;290(7):880. doi:10.1001/jama.290.7.880-a